LEXINGTON, Mass.–(BUSINESS WIRE)–Apr. 3, 2025– Aldeyra Therapeutics, Inc...
Author - David Miller
New alloys for manufacturing freeze-dryers
This article explores the challenges found in manufacturing of a pressure vessel as main component...
Navigating the Complexities of Emerging Therapy Development
Advancement of emerging therapies faces hurdles across all aspects and phases of drug development...
INTERPHEX 2025: Preventing Spills in the Manufacturing Process
Joe Bobacher of OPW Engineered Systems spoke with Pharmaceutical Technology® Group at INTERPHEX...
Agentic AI Growth Predicted, but More Than Half of Pharma Still...
Lack of skills in the AI realm was a distant second among those surveyed about the biggest barrier...
Microsoft and SkyCell Collaborate on Pharma Supply Chain...
SkyCell is working with Microsoft to incorporate SkyCell’s AI-powered supply chain solution into...
Siemens Acquires Dotmatics, Extending AI Software Portfolio into...
Siemens said spending on AI software is predicted to double by the end of the 2020s, in a market...
Industry Outlook 2025: Cell Therapy Advancement
The PharmTech Group interviewed Edwin Stone, CEO of Cellular Origins, about the bio/pharmaceutical...
Executive Summary: Commercial Tech Transfers in OSD Manufacturing
Collaborating with a CDMO that has the necessary expertise, equipment, and systems in place...
Getting JUV-161 to Phase I in 2025
Hanadie Yousef, PhD, co-founder and CEO of Juvena Therapeutics, discusses getting JUV-161 into...